Global Cancer Diagnostics Market is expected to reach USD 18.4 billion by 2024 from USD 7.6 billion in 2016, at a CAGR of 11.7% by 2024.

DALLAS, TEXAS, UNITED STATES, June 19, 2017 /EINPresswire.com/ -- Global Cancer Diagnostics Market By Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melonoma), By Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the World) – Trends and Forecast to 2024

The Cancer Diagnostics Market is segmented on the basis of technology and application.

Based on geography, the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The geographical regions are further segmented into 29 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and others.

For a Sample of the report: http://databridgemarketresearch.com/reports/global-cancer-diagnostics-market/

By Technology:
• ELISA
• ELFA
• PCR
• NGS
• Immunohistochemistry
• Microarray
• Imaging
 MRI
 CT
 PET
 Ultrasound
 Mammography
• Biopsy

By Application:
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Melonoma

Key factors propelling growth of this market are technological advancements in the diagnostics imaging systems, growing number of cancer patients globally, rapidly aging population, and huge government support for research in cancer diagnostics. However, factors such as the dearth of skilled professionals and high capital investments for imaging systems are restraining the growth of the market.


Read More on the market trends of Global Cancer Diagnostics Market: http://databridgemarketresearch.com/global-cancer-diagnostics-market-poised-grow-11-7-till-2024/

Some of the major players operating in this market are Abbott Laboratories, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., Becton, Dickinson and Company, GE Healthcare, QIAGEN N.V., Agilent Technologies, Inc., Roche Diagnostics, Siemens Healthcare, Philips Healthcare, and C.R. Bard, Inc., Hologic, Inc. among other players.


Table Of Contents:

1. INTRODUCTION
1.1. OVERVIEW OF THE GLOBAL CANCER DIAGNOSTICS MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL CANCER DIAGNOSTICS MARKET SIZE
2.3. GLOBAL CANCER DIAGNOSTICS MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.2. RESTRAINTS
3.3. OPPORTUNITIES
3.4. CHALLENGES
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1. OVERVIEW
6.2. PLATFORM BASED, BY PRODUCT TYPE
6.3. INSTRUMENT BASED, BY PRODUCT TYPE
6.3.1. IMAGING
6.3.2. BIOPSY
7. GLOBAL CANCER DIAGNOSTICS MARKET, BY APPLICATION
7.1. OVERVIEW
7.2. LUNG CANCER
7.3. BREAST CANCER
7.4. COLORECTAL CANCER
7.5. MELANOMA
7.6. OTHERS
9. GLOBAL CANCER DIAGNOSTICS MARKET, BY GEOGRAPHY
9.1. COUNTRYWISE GLOBAL CANCER DIAGNOSTICS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
9.1.1. NORTH AMERICA
9.1.2. EUROPE
9.1.3. ASIA-PACIFIC (APAC)
9.1.4. LATIN AMERICA
9.1.5. MIDDLE EAST AND AFRICA
9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
10. GLOBAL CANCER DIAGNOSTICS MARKET: COMPETITIVE LANDSCAPE
10.1. GLOBAL CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS
10.2. NORTH AMERICA CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS
10.3. EUROPE CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS
10.4. APAC CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS
10.5. MEA CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS
10.6. SOUTH AMERICA CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS
10.7. MERGERS & ACQUISITIONS
10.8. NEW PRODUCT DEVELOPMENT & APPROVALS
10.9. EXPANSIONS
10.10. REGULATORY CHANGES
10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
11. GLOBAL CANCER DIAGNOSTICS MARKET, COMPANY PROFILES
11.1. ABBOTT
11.2. THERMO FISHER SCIENTIFIC
11.3. ILLUMINA, INC.
11.4. GE HEALTHCARE
11.5. SIEMENS HEALTHCARE GMBH
11.6. QIAGEN
11.7. AGILENT TECHNOLOGIES
11.8. ROCHE DIAGNOSTICS
11.9. KONINKLIJKE PHILIPS N.V.
11.10. BECTON, DICKINSON & COMPANY
11.11. C.R. BARD, INC.
11.12. HOLOGIC, INC.
12. APPENDIX
13. ABOUT DATA BRIDGE MARKET RESEARCH

Varsha Chaudhari
Data Bridge Market Research Private Ltd.
+1-888-387-2818
email us here